Terms: = Colorectal cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Diagnosis
45 results:
1. ARHGAP4 promotes colon cancer metastasis through the TGF-β signaling pathway and may be associated with T cell exhaustion.
Jiang S; Tang Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
Biochem Biophys Res Commun; 2024 Aug; 722():150172. PubMed ID: 38805788
[TBL] [Abstract] [Full Text] [Related]
2. Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions.
Sharma S; Singh N; Turk AA; Wan I; Guttikonda A; Dong JL; Zhang X; Opyrchal M
World J Gastroenterol; 2024 Apr; 30(13):1815-1835. PubMed ID: 38659481
[TBL] [Abstract] [Full Text] [Related]
3. Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer.
Maggadottir SM; Dueland S; Mensali N; Hamre H; Andresen PA; Myhre MR; Juul HV; Bigalke I; Lundby M; Hønnåshagen TK; Sæbøe-Larssen S; Josefsen D; Hagtvedt T; Wälchli S; Kvalheim G; Inderberg EM
Mol Ther; 2024 Jun; 32(6):2021-2029. PubMed ID: 38582964
[TBL] [Abstract] [Full Text] [Related]
4. Exploring the clinical significance of IL-38 correlation with pd-1, CTLA-4, and FOXP3 in colorectal cancer draining lymph nodes.
Yuan L; Tan Z; Huang J; Chen F; Hambly BD; Bao S; Tao K
Front Immunol; 2024; 15():1384548. PubMed ID: 38533512
[TBL] [Abstract] [Full Text] [Related]
5. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
[TBL] [Abstract] [Full Text] [Related]
6. Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy.
Cheng S; Han Z; Dai D; Li F; Zhang X; Lu M; Lu Z; Wang X; Zhou J; Li J; Guo X; Song P; Qiu C; Shen W; Zhang Q; Zhu N; Wang X; Tan Y; Kou Y; Yin X; Shen L; Peng Z
Cell Rep Med; 2024 Jan; 5(1):101355. PubMed ID: 38194971
[TBL] [Abstract] [Full Text] [Related]
7. Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases.
Peng K; Li Y; Su H; Lan C; Huang Z; Wei Y; Liao X; Peng M; Peng T; Zhu G
Front Immunol; 2023; 14():1325445. PubMed ID: 38173715
[TBL] [Abstract] [Full Text] [Related]
8. Sarcoma in patients with Lynch syndrome and response to immunotherapy.
Shehata MS; Lofftus SY; Park JY; Singh AS; Federman NC; Eilber FC; Crompton JG; McCaw TR
J Surg Oncol; 2024 Mar; 129(4):820-826. PubMed ID: 38151827
[TBL] [Abstract] [Full Text] [Related]
9. CHSY1 promotes CD8
Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
[TBL] [Abstract] [Full Text] [Related]
10. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition.
Mishima S; Naito Y; Akagi K; Hayashi N; Hirasawa A; Hishiki T; Igarashi A; Ikeda M; Kadowaki S; Kajiyama H; Kato M; Kenmotsu H; Kodera Y; Komine K; Koyama T; Maeda O; Miyachi M; Nishihara H; Nishiyama H; Ohga S; Okamoto W; Oki E; Ono S; Sanada M; Sekine I; Takano T; Tao K; Terashima K; Tsuchihara K; Yatabe Y; Yoshino T; Baba E
Int J Clin Oncol; 2023 Oct; 28(10):1237-1258. PubMed ID: 37599324
[TBL] [Abstract] [Full Text] [Related]
11. Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from colorectal cancer.
Greco L; Rubbino F; Dal Buono A; Laghi L
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372349
[TBL] [Abstract] [Full Text] [Related]
12. Pathological complete response after neoadjuvant immunotherapy combined with chemotherapy in pediatric rectal carcinoma: A case report.
Cao X; Luo J; Zhao B; Fu H; Kang W
Front Immunol; 2022; 13():1036181. PubMed ID: 36544760
[TBL] [Abstract] [Full Text] [Related]
13. Tumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapy.
Prakash A; Gates T; Zhao X; Wangmo D; Subramanian S
Pharmacol Ther; 2023 Jan; 241():108332. PubMed ID: 36526013
[TBL] [Abstract] [Full Text] [Related]
14. Case report: Camrelizumab associated with central retinal vein occlusion.
Zhan Y; Zhao W; Ni K; Liu Z; Su Y; Li X; Zhang H; Zhang C
Front Immunol; 2022; 13():1025125. PubMed ID: 36505454
[TBL] [Abstract] [Full Text] [Related]
15. Microsatellite instability/mismatch repair deficiency and activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland: A case report.
Yang G
Medicine (Baltimore); 2022 Aug; 101(34):e30311. PubMed ID: 36042639
[TBL] [Abstract] [Full Text] [Related]
16. Roles of circulating tumor DNA in pd-1/PD-L1 immune checkpoint Inhibitors: Current evidence and future directions.
Liu Z; Han Y; Dang Q; Xu H; Zhang Y; Duo M; Lv J; Li H; Kong Y; Han X
Int Immunopharmacol; 2022 Oct; 111():109173. PubMed ID: 35998502
[TBL] [Abstract] [Full Text] [Related]
17. colorectal cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
Aristin Revilla S; Kranenburg O; Coffer PJ
Front Immunol; 2022; 13():903564. PubMed ID: 35874729
[TBL] [Abstract] [Full Text] [Related]
18. Keratoacanthoma or cutaneous squamous cell carcinoma revealing a DNA mismatch repair default (Muir-Torre Syndrome).
Miao Y; Kolb F; Tomasic G; Lupu J; Routier E; Robert C
J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():74-76. PubMed ID: 34855250
[TBL] [Abstract] [Full Text] [Related]
19. Programmed cell death protein-1 inhibitors in the treatment of digestive system tumors in Chinese population: an observational study of effectiveness and safety.
Yang W; Chang L; Guo Q; Chen J; Yu W; Zhang W
Ann Palliat Med; 2021 Aug; 10(8):9015-9024. PubMed ID: 34488388
[TBL] [Abstract] [Full Text] [Related]
20. MSI testing : What's new? What should be considered?
Rüschoff J; Baretton G; Bläker H; Dietmaier W; Dietel M; Hartmann A; Horn LC; Jöhrens K; Kirchner T; Knüchel R; Mayr D; Merkelbach-Bruse S; Schildhaus HU; Schirmacher P; Tiemann M; Tiemann K; Weichert W; Büttner R
Pathologe; 2021 Nov; 42(Suppl 1):110-118. PubMed ID: 34477921
[TBL] [Abstract] [Full Text] [Related]
[Next]
